Charles River Laboratories International (CRL) FCF Margin (2009 - 2026)
Charles River Laboratories International (CRL) posted FCF Margin of 14.8% for Q2 2026, up 1093.86% on a QoQ basis from 1.49% in Q1 2026, and down 160.0% year-over-year from 24.67% in Q2 2025.
Analysis
Charles River Laboratories International (CRL) FCF Margin (2009 - 2026) Analysis & Trends
Charles River Laboratories International has reported FCF Margin for 18 years, with the latest figure at 14.8% in Q2 2026.
- On a quarterly basis, FCF Margin fell 160.0% year-over-year to 14.8% in Q2 2026; TTM through Jun 2026 was 9.27%, a 509.0% decrease from a year earlier, with the FY2025 full-year figure at 12.91%, up 53.0% from the prior year.
- FCF Margin was 14.8% for Q2 2026 at Charles River Laboratories International, up from 1.49% in the prior quarter.
- The five-year high for FCF Margin was 21.1% in Q3 2024, with the low at 1.49% in Q1 2026.
- Average FCF Margin over 5 years is 9.91%, with a median of 9.89% recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: FCF Margin tumbled 1482 bps in 2022, then jumped 751 bps in 2024.
- Over 5 years, FCF Margin stood at 13.25% in 2022, then gained by 6 bps to 14.07% in 2023, then tumbled by 41 bps to 8.35% in 2024, then slipped by 29 bps to 5.89% in 2025, then surged by 151 bps to 14.8% in 2026.
- The last three FCF Margin figures came in at 14.8% (Q2 2026), 1.49% (Q1 2026), and 5.89% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 8.24% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 19.52% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 15.69% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 14.80% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.93% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -232.65% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -4.05% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -103.39% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -17,977.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 14.80% |
| Mar 28, 2026 | -1.49% |
| Dec 27, 2025 | 5.89% |
| Sep 27, 2025 | 17.74% |
| Jun 28, 2025 | 16.40% |
| Mar 29, 2025 | 11.42% |
| Dec 28, 2024 | 8.35% |
| Sep 28, 2024 | 21.10% |
| Jun 29, 2024 | 15.01% |
| Mar 30, 2024 | 5.02% |
| Dec 30, 2023 | 14.07% |
| Sep 30, 2023 | 13.59% |
| Jul 1, 2023 | 7.62% |
| Apr 1, 2023 | 0.24% |
| Dec 31, 2022 | 13.25% |
| Sep 24, 2022 | 6.10% |
| Jun 25, 2022 | 6.85% |
| Mar 26, 2022 | 2.43% |
| Dec 25, 2021 | 14.42% |
| Sep 25, 2021 | 13.30% |